| |
| |
|
| Insider
Information: |
Sabag Mark |
| Relationship: |
|
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
382,590 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,283,568 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
382,590 |
|
|
| Total
Value |
$5,283,568 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -60.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
|
2024-03-05 |
382,590 |
2018-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2024-03-05 |
4 |
S |
$13.52 |
$1,352,090 |
D/D |
(100,000) |
382,590 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
81,897 |
482,590 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
400,693 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,900 |
367,181 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,599 |
342,281 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,764 |
321,682 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,433 |
297,918 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,840 |
248,485 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,764 |
177,645 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,278 |
153,881 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,598 |
94,603 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,523 |
74,005 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,884 |
58,482 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-03-16 |
4 |
S |
$11.22 |
$1,427,614 |
D/D |
(127,244) |
20,598 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,920 |
147,842 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,598 |
131,922 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,712 |
111,324 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
65,339 |
105,612 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,523 |
40,273 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,750 |
24,750 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2020-02-13 |
4 |
S |
$13.03 |
$939,760 |
D/D |
(72,131) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
See Remarks below |
• – – |
2020-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,523 |
72,131 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Global Human Resources |
• – – |
2019-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,710 |
56,608 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Global Human Resources |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,381 |
50,898 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Global Human Resources |
• – – |
2018-02-15 |
4 |
S |
$20.52 |
$61,560 |
D/D |
(3,000) |
41,517 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
